Savitz Ryan bought DNTH
December 4, 2025 · Form 4 insider transaction
Savitz Ryan bought 20,000 shares of Dianthus Therapeutics, Inc. at $8.44 per share, a transaction worth $168.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$8.44
Total value
$168.8K
InsiderSavitz Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 4, 2025
Filing dateDecember 5, 2025
Shares owned after20,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025.